Earnings · China A-shares
Hangzhou Biotest Biotech Co., Ltd. Class A (688767) earnings
Hangzhou Biotest Biotech Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -174.87% year on year, -247.71% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -5.54% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -174.87%
- Excl. one-offs YoY
- -247.71%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.83% | — |
| 3 days | -5.54% | — |
| 7 days | +1.33% | — |
| 14 days | -2.16% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -1.78%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | -¥16.67M | -174.87% | — | +1.33% | -0.11 | -0.73% | -5.54% | — | — |
| 2026 interim report | 2026-08-29 | -¥16.55M | -233.46% | — | +5.61% | -0.11 | -0.71% | +2.51% | +4.43% | +13.77% |
| 2026 Q1 report | 2026-04-25 | -¥10.21M | -216.90% | — | +1.70% | -0.07 | -0.43% | -1.37% | +7.69% | +7.99% |
| 2025 annual report | 2026-04-25 | ¥49.25M | -70.94% | -77.36% | -19.91% | 0.34 | 2.07% | -1.37% | +7.69% | +7.99% |
| 2025 Q3 report | 2025-10-30 | ¥22.26M | -75.04% | -81.40% | -20.76% | 0.14 | 0.94% | -5.84% | -13.90% | -9.16% |
| 2025 interim report | 2025-08-29 | ¥12.40M | -82.82% | -90.25% | -23.91% | 0.07 | 0.52% | +1.96% | -1.98% | -3.26% |
| 2025 Q1 report | 2025-04-26 | ¥8.73M | -77.97% | -83.84% | -35.20% | 0.06 | 0.36% | -2.41% | -18.30% | -21.55% |
| 2024 annual report | 2025-04-26 | ¥169.52M | +59.01% | +50.19% | +26.53% | 1.15 | 7.03% | -2.41% | -18.30% | -21.55% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.